Enzon Pharma (ENZN) to Trim Workforce by About Half

Go back to Enzon Pharma (ENZN) to Trim Workforce by About Half

Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale

December 17, 2012 7:03 AM EST

Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced that its Board of Directors has retained Lazard to act as financial advisor in a review of the possible sale or disposition of one or more corporate assets, or a sale of the Company.

Based on... More